Why is the Fed hesitant on December rate cuts?
How did Nvidia calm AI bubble fears?
Why is Verizon cutting 13,000 jobs now?
What drove Walmart’s rising e-commerce sales?
How will Trump’s AI regulation affect states?
Why is Japan increasing foreign residency fees?
What impacts do rare-earth export shifts have?
Johnson & Johnson set to revolutionize the treatment of cancer with the acquisition of Halda Therapeutics
jnj.com/media-center/press-releases/johnson-johnson-set-to-revolutionize-the-treatment-of-cancer-with-the-acquisition-of-halda-therapeuticsNEW BRUNSWICK, NJ (November 17, 2025) – Johnson & Johnson (NYSE: JNJ) announced today that it has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc. (Halda), a clinical-stage biotechnology company with a proprietary Regulated Induced Proximity TArgeting Chimera…
This story appeared on jnj.com, 2025-11-17 15:44:23.112000.